Similarly, pre-clinical RA patients who tested positive for anti-CCP2 and SE also had markedly reduced levels of FA 20:5 ω-3; 22:6 ω-3; total ω-3 FA% and 20:5 + 22:6 [136]. Here, AGBL2 is linked to rheumatoid arthritis.